Partners Gary Giampetruzzi, Joy Dowdle and Leo Tsao are proud to participate at the American Conference Institute’s 14th Advanced Forum FCPA & Anti-Corruption for the Life Sciences Industry on July 21-22 in Boston, Massachusetts.

Gary will be speaking on a panel titled “Managing the New Realities of Operating in China: How Life Sciences Companies Have Updated Their Compliance Roadmaps” with William Simmons, Head of Global Investigations; Associate Director, Ethics & Compliance at Lonza, Danielle Cartron, ABAC and Trade Compliance Counsel at Incyte, and Jonathan Mehta, Legal Director, Litigation & Investigations-Asia Pacific at Johnson & Johnson on July 21 at 11:45am ET.

Joy will be speaking on a panel titled “Clinical Trials – The Latest on Managing Unique, Evolving Bribery Risk Factors” with  David Ralston, Senior Vice President Deputy General Counsel at Taysha Gene Therapies, Natasha Trifun, Executive Director, Head of Compliance R&D at Alexion, and Peter Jensen, Vice President, Risk Management & Compliance at Arthrex on July 22 at 11:45am ET.

Leo will be speaking on a panel titled “Former DOJ Officials Predict the Future of FCPA Investigations and Enforcement: Special Considerations for Pharmaceutical, Medical Device and Biotech Companies, and CROs” on July 21 at 11:00am ET.

For more information and to register, visit the American Conference Institute’s website here.